Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L R Lund

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
FEBS Letters|April 1, 1996
Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell linesL R Lund
FEBS Letters|February 24, 1992
Okadaic acid strongly increases gene transcription, mRNA and protein level for the urokinase receptor in human A549 cellsL R Lund, K Danø
Ugeskrift for Laeger|January 2, 1989
[Basic cancer biology]K Danø, L R Lund, J Zeuthen
Nature Medicine|November 14, 1997
Healing hormonesJ Rømer, L R Lund, K Danø
The Journal of Investigative Dermatology|July 1, 1995
Neutrophils express tumor necrosis factor-alpha during mouse skin wound healingE Feiken, J Rømer, J Eriksen, et al.
The Journal of Investigative Dermatology|April 1, 1996
Differential expression of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse skin after exposure to a tumor-promoting phorbol esterL R Lund, J Eriksen, E Ralfkiaer, et al.
Endocrinology|May 1, 1990
Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated ratsP A Andreasen, P Kristensen, L R Lund, et al.
European Journal of Biochemistry|February 14, 1991
A tetranectin-related protein is produced and deposited in extracellular matrix by human embryonal fibroblastsI Clemmensen, L R Lund, L Christensen, et al.
Current Opinion in Cell Biology|November 18, 1998
Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradationM Johnsen, L R Lund, J Rømer, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1995
Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptorB Casslén, J Nordengren, B Gustavsson, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
FEBS Letters|April 1, 1996
Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell linesL R Lund
FEBS Letters|February 24, 1992
Okadaic acid strongly increases gene transcription, mRNA and protein level for the urokinase receptor in human A549 cellsL R Lund, K Danø
Ugeskrift for Laeger|January 2, 1989
[Basic cancer biology]K Danø, L R Lund, J Zeuthen
Nature Medicine|November 14, 1997
Healing hormonesJ Rømer, L R Lund, K Danø
The Journal of Investigative Dermatology|July 1, 1995
Neutrophils express tumor necrosis factor-alpha during mouse skin wound healingE Feiken, J Rømer, J Eriksen, et al.
The Journal of Investigative Dermatology|April 1, 1996
Differential expression of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse skin after exposure to a tumor-promoting phorbol esterL R Lund, J Eriksen, E Ralfkiaer, et al.
Endocrinology|May 1, 1990
Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated ratsP A Andreasen, P Kristensen, L R Lund, et al.
European Journal of Biochemistry|February 14, 1991
A tetranectin-related protein is produced and deposited in extracellular matrix by human embryonal fibroblastsI Clemmensen, L R Lund, L Christensen, et al.
Current Opinion in Cell Biology|November 18, 1998
Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradationM Johnsen, L R Lund, J Rømer, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1995
Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptorB Casslén, J Nordengren, B Gustavsson, et al.
Pageof 7